This blog is brought to you by ADVANCE and DNA. Editor's note: This blog post was written by Victoria Lazareth, MA, MSN, NP-C, DCNP, national chairwoman of the Dermatology Nurse Practitioner Society.She practices in the Division of Dermatology at the University of Massachusetts Memorial Medical Center in Worcester, Mass. She is also ...

First there was Botox, then there was Dysport, and now there is Xeomin (incobotulinumtoxinA). Xeomin is the latest addition to a growing list of botulinum toxin type A injectables. The Food and Drug Administration recently approved this new botulinum product to treat severe frown lines between the eyebrows, and I'm anxiously waiting for its ...